Dr. Deborah Yurgelun-Todd, Ph.D.
Claim this profileMore about Deborah Yurgelun-Todd, Ph.D.
Clinical Trial Related
8 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Deborah Yurgelun-Todd, Ph.D. has experience with
- Cannabidiol
- Delta-9-Tetrahydrocannabinol
- Placebos
Breakdown of trials Deborah Yurgelun-Todd, Ph.D. has run
Chronic Pain
Fibromyalgia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah Yurgelun-Todd, Ph.D. specialize in?
Deborah Yurgelun-Todd, Ph.D. focuses on Chronic Pain and Fibromyalgia. In particular, much of their work with Chronic Pain has involved treating patients, or patients who are undergoing treatment.
Is Deborah Yurgelun-Todd, Ph.D. currently recruiting for clinical trials?
No, Deborah Yurgelun-Todd, Ph.D. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Deborah Yurgelun-Todd, Ph.D. has studied deeply?
Yes, Deborah Yurgelun-Todd, Ph.D. has studied treatments such as Cannabidiol, Delta-9-Tetrahydrocannabinol, Placebos.
What is the best way to schedule an appointment with Deborah Yurgelun-Todd, Ph.D.?
Apply for one of the trials that Deborah Yurgelun-Todd, Ph.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.